You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TR-701

Showing 1 - 25 of 410
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Gainesville (TR-700 (active moiety), TR-701 (pro-drug))

Completed
  • Healthy
  • TR-700 (active moiety)
  • TR-701 (pro-drug)
  • Gainesville, Florida
    General Clinical Research Center
Nov 13, 2019

Skin Diseases, Infectious, Skin Diseases, Bacterial Trial in United States (TR-701 200 mg, TR-701 300 mg, TR-701 400 mg)

Completed
Has Results
  • Skin Diseases, Infectious
  • Skin Diseases, Bacterial
  • TR-701 200 mg
  • +2 more
  • Dothan, Alabama
  • +11 more
Nov 11, 2019

Healthy Trial in Madison (Human ADME)

Completed
  • Healthy
  • Human ADME
  • Madison, Wisconsin
    Trius Investigator Site 001
Nov 13, 2019

Bacterial Infection Trial in Hartford (TR-701 FA)

Completed
  • Bacterial Infection
  • TR-701 FA
  • Hartford, Connecticut
    Trius Investigator Site 001
Nov 13, 2019

Gram-Positive Bacterial Infections Trial (Tedizolid Phosphate (IV), Tedizolid Phosphate (oral suspension))

Completed
Has Results
  • Gram-Positive Bacterial Infections
  • Tedizolid Phosphate (IV)
  • Tedizolid Phosphate (oral suspension)
  • (no location specified)
Dec 2, 2019

Pneumonia Trial (Tedizolid phosphate, Linezolid)

Completed
Has Results
  • Pneumonia
  • (no location specified)
Jun 10, 2019

Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (efgartigimod PH20 SC, prednisone)

Recruiting
  • Pemphigus Vulgaris
  • Pemphigus Foliaceus
  • Birmingham, Alabama
  • +120 more
Dec 22, 2022

Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)

Recruiting
  • Pemphigus Vulgaris
  • Pemphigus Foliaceus
  • efgartigimod PH20 SC
  • +2 more
  • Birmingham, Alabama
  • +130 more
Dec 22, 2022

Healthy Volunteer Trial in Dallas (TR-701 FA 1200 mg, Moxifloxacin 400 mg, TR-701 FA 200 mg plus Placebo)

Completed
  • Healthy Volunteer
  • TR-701 FA 1200 mg
  • +3 more
  • Dallas, Texas
    Trius Investigator
Dec 3, 2018

Skin Diseases, Infectious, Skin Diseases, Bacterial Trial (Tedizolid Phophate, Antibiotic comparator, Aztreonam)

Completed
Has Results
  • Skin Diseases, Infectious
  • Skin Diseases, Bacterial
  • Tedizolid Phophate
  • +3 more
  • (no location specified)
Jul 12, 2019

Tumor Metastasis / Bone and Bones Trial in Worldwide (Data Collection)

Recruiting
  • Neoplasm Metastasis / Bone and Bones
  • Data Collection
  • Anchorage, Alaska
  • +156 more
Aug 22, 2022

Relapsed/Refractory Multiple Myeloma Trial in Worldwide (AMG 701, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Relapsed/Refractory Multiple Myeloma
  • AMG 701
  • +2 more
  • Scottsdale, Arizona
  • +33 more
Nov 29, 2022

Late-onset Pompe Disease Trial in Gainesville, London (Respiratory muscle strength measurements by different techniques.)

Terminated
Has Results
  • Late-onset Pompe Disease
  • Respiratory muscle strength measurements by different techniques.
  • Gainesville, Florida
  • +1 more
Apr 11, 2022

Healthy Subjects Trial in Overland Park (TR-701 FA with PSE, TR-701 FA Placebo with PSE)

Completed
  • Healthy Subjects
  • TR-701 FA with PSE
  • TR-701 FA Placebo with PSE
  • Overland Park, Kansas
    Trius Investigator Site 001
Aug 19, 2018

Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial

Not yet recruiting
  • Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency
  • +2 more
  • INZ-701
  • Control Arm (Conventional Therapy)
  • (no location specified)
Sep 18, 2023

Healthy Trial in Adelaide (TR-01-XRR (1), TR-01-XRR (2), TR-01-XRR (3))

Not yet recruiting
  • Healthy
  • TR-01-XRR (1)
  • +6 more
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Feb 3, 2023

Geographic Atrophy Insights (i-GAIN) Natural History Study

Recruiting
  • Dry Age-related Macular Degeneration
  • +6 more
    • Belfast, United Kingdom
    • +11 more
    Mar 22, 2023

    Severe Functional TR According to Medical, Transcatheter or

    Enrolling by invitation
    • Tricuspid Regurgitation
    • Surgery or Transcatheter tricuspid valve intervention
    • Rochester, Minnesota
    • +43 more
    Apr 21, 2023

    Acute Myocardial Infarction, Heart Failure Trial in Sweden, United Kingdom (Dapagliflozin, Placebo)

    Recruiting
    • Acute Myocardial Infarction
    • Heart Failure
    • AlingsÃ¥s, Sweden
    • +112 more
    Aug 18, 2022

    Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial

    Not yet recruiting
    • Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
    • +2 more
    • (no location specified)
    Feb 15, 2023

    Parkinson's Disease Trial in Cassino, Roma (VRRS Tablet (Khymeia s.r.l., Noventa Padovana, Italy), Conventional rehabilitation)

    Recruiting
    • Parkinson's Disease
    • VRRS Tablet (Khymeia s.r.l., Noventa Padovana, Italy)
    • Conventional rehabilitation
    • Cassino, Frosinone, Italy
    • +1 more
    Mar 6, 2023

    Major Cutaneous Abscess, Cellulitis, Erysipelas Trial in United States (TR701 FA)

    Completed
    Has Results
    • Major Cutaneous Abscess
    • +2 more
    • TR701 FA
    • Anaheim, California
    • +9 more
    Jul 31, 2018

    Tricuspid Regurgitation Trial in Seoul (Dapagliflozin Propanediol Hydrate 12.3 mg)

    Recruiting
    • Tricuspid Regurgitation
    • Dapagliflozin Propanediol Hydrate 12.3 mg
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jan 9, 2023

    Tricuspid Valve Regurgitation in Cardiac Implantable Electronic

    Completed
    • Tricuspid Regurgitation
    • Tricuspid valve surgery
    • Milan, Italy
      IRCCS Ospedale San Raffaele
    Mar 16, 2023

    Symptomatic Severe Tricuspid Regurgitation Trial in Italy (TriFlo Tricuspid Flow Optimizer)

    Not yet recruiting
    • Symptomatic Severe Tricuspid Regurgitation
    • TriFlo Tricuspid Flow Optimizer
    • Castel Volturno, Caserta, Italy
    • +3 more
    Oct 16, 2023